Subscriber: th..@boehringer-ingelheim.com
HIV Infection
18 September 2017 | n=0
Display articles in
|
 |
|
Amedeo HIV Infection
Data Origin
You selected the following journals for your Amedeo HIV Infection newsletter:
AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.
To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.
|
|
|
|
Amedeo HIV Infection
Five-Week Literature
|
|
|
|
18 September 2017
Multidisciplinary Journal Club
- Sax PE, Pozniak A, Montes ML, Koenig E, et al.
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre%
Lancet. 2017 Aug 31. pii: S0140-6736(17)32340.
- Gallant J, Lazzarin A, Mills A, Orkin C, et al.
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-in
Lancet. 2017 Aug 31. pii: S0140-6736(17)32299.
- Corren J, Parnes JR, Wang L, Mo M, et al.
Tezepelumab in Adults with Uncontrolled Asthma.
N Engl J Med. 2017;377:936-946.
Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.
|
|
|
|
